Edap TMS SA (EDAP)
2.81
-0.06
(-2.09%)
USD |
NASDAQ |
Sep 27, 16:00
2.77
-0.04
(-1.42%)
After-Hours: 20:00
Edap TMS Accounts Receivable (Quarterly): 19.52M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 19.52M |
March 31, 2024 | 18.37M |
December 31, 2023 | 19.00M |
September 30, 2023 | 17.26M |
June 30, 2023 | 19.58M |
March 31, 2023 | 18.86M |
December 31, 2022 | 13.90M |
September 30, 2022 | 14.87M |
June 30, 2022 | 16.60M |
March 31, 2022 | 13.34M |
December 31, 2021 | 12.45M |
September 30, 2021 | 11.78M |
June 30, 2021 | 13.31M |
March 31, 2021 | 12.03M |
December 31, 2020 | 13.98M |
September 30, 2020 | 13.59M |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 12.69M |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 13.59M |
September 30, 2018 | |
June 30, 2018 | 13.96M |
Date | Value |
---|---|
March 31, 2018 | |
December 31, 2017 | 13.53M |
September 30, 2017 | |
June 30, 2017 | 11.82M |
March 31, 2017 | |
December 31, 2016 | 9.666M |
September 30, 2016 | |
June 30, 2016 | 10.34M |
March 31, 2016 | |
December 31, 2015 | 11.75M |
September 30, 2015 | |
June 30, 2015 | 10.23M |
March 31, 2015 | |
December 31, 2014 | 8.443M |
September 30, 2014 | |
June 30, 2014 | 10.23M |
March 31, 2014 | |
December 31, 2013 | 10.90M |
September 30, 2013 | |
June 30, 2013 | 9.875M |
March 31, 2013 | |
December 31, 2012 | 14.74M |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
11.78M
Minimum
Sep 2021
19.58M
Maximum
Jun 2023
15.36M
Average
13.98M
Median
Dec 2020
Accounts Receivable (Quarterly) Benchmarks
DBV Technologies SA | -- |
Genfit SA | 20.48M |
Cellectis SA | 9.741M |
Adaptimmune Therapeutics PLC | 2.335M |
Akari Therapeutics PLC | -- |